Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNSE
SNSE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNSE News
Sensei Biotherapeutics Reports Significant Q1 Losses Amid Pipeline Developments
May 19 2026
NASDAQ.COM
Sensei Biotherapeutics Reports Q1 2026 Financial Results and Clinical Updates
May 15 2026
Newsfilter
GT Biopharma Initiates Phase 1 Trial of GTB-5550 for Solid Tumors
May 14 2026
Newsfilter
Sensei Biotherapeutics Launches PIKTOR Clinical Trial for Advanced Breast Cancer
May 05 2026
Newsfilter
SENSEI Biotherapeutics Administers First Dose to Patient in Phase 1B/2 Trial of PIKTOR for HR+/HER2- Advanced Breast Cancer
May 05 2026
moomoo
Surge in Short Selling of Small-Cap Healthcare Stocks
May 04 2026
seekingalpha
Sensei Biotherapeutics Reports Increased Losses in FY Earnings
Mar 30 2026
seekingalpha
Biotech Investment Revives as Institutional Capital Flows Back
Mar 19 2026
Globenewswire
Sensei Biotherapeutics Grants Stock Options to New Employee
Mar 17 2026
Newsfilter
Sensei Biotherapeutics Grants Stock Options to New Employees
Feb 25 2026
Newsfilter
Sensei Biotherapeutics Secures $200 Million Financing and Acquires Faeth
Feb 18 2026
stocktwits
U.S. Stocks Rise, Nasdaq Gains Over 1%
Feb 18 2026
Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M
Feb 18 2026
seekingalpha
U.S. Stocks Rise in Morning Trading, Dow Up Approximately 100 Points
Feb 18 2026
Benzinga
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
What Caused Sensei Biotherapeutics (SNSE) Stock to Surge Nearly 63% in After-Hours Trading?
Dec 05 2025
Benzinga
Show More News
